EVP and General Counsel of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), Halstead Michael, sells 11,139 shares worth $437,133
According to Intra-Cellular Therapies, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 22 08:03 PM, company EVP and General Counsel, Halstead Michael disclosed selling 11,139 shares at a cost of $39.24. At the time of this transaction (Feb 19), this trade was worth $437,133 in total. As of Feb 19, Halstead Michael now owns 0 shares in total worth about $0.0.
For the last few recent trades made by Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) EVP and General Counsel, Halstead Michael, we have the following information:
- SEC Form 4 filing: Jan 11: Sold 19,638 shares at the rate of $32.03 per share. Total worth of this trade was $628,978. Total number of shares owned as of Jan 11 were 0
- SEC Form 4 filing: Jan 04: Sold 16,160 shares at the rate of $31.30 per share. Total worth of this trade was $505,834. Total number of shares owned as of Jan 04 were 0
- SEC Form 4 filing: Nov 17: Sold 79,425 shares at the rate of $27.62 per share. Total worth of this trade was $2,193,446. Total number of shares owned as of Nov 17 were 0
Posted by
George Daniels
on Monday February 22 2021, 11:54 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
